MML Investors Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
PAM
CI
MML Investors Services's PJP Position: Q1 2026 in Review
MML Investors Services opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q1 2026: 27,534 shares worth $2.86M. The stake represents 0.01% of the portfolio and ranks #1118 among its holdings. This is a return to the name: MML Investors Services previously reported a position in PJP as recently as Q1 2022.
MML Investors Services first reported a position in PJP in Q3 2018 and has held it in 12 quarters since. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.
- MML Investors Services held 27,534 shares of Invesco Pharmaceuticals ETF worth $2.86M as of Q1 2026.
- Invesco Pharmaceuticals ETF was a new MML Investors Services position in Q1 2026.
- Invesco Pharmaceuticals ETF made up 0.01% of MML Investors Services's portfolio in Q1 2026, its #1118 holding.
- MML Investors Services first reported a position in Invesco Pharmaceuticals ETF in Q3 2018 and has held it in 12 quarters since.
- 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.
Based on MML Investors Services's 13F filing for Q1 2026, filed 4 May 2026.